FDA approves sublingual hay fever immunotherapeutic.
Eva M
EM
Riedmann
D000293:Adolescent; D000328:Adult; D000368:Aged; D017277:Drug Approval; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008875:Middle Aged; D006255:Rhinitis, Allergic, Seasonal / Q000628:therapy*; D014481:United States; D014486:United States Food and Drug Administration; D055815:Young Adult